Currently, the main clinical use of PDE5 inhibitors involves the treatment of erectile dysfunction, whose mechanism occurs through decreasing the catalytic activity of the PDE5 enzyme in the vascular smooth muscle of the penis. Here, PDE5A is linked to erectile dysfunction.